Artelo Biosciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15th   

LA JOLLA, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, today announced that it will be presenting at the H.C. Wainwright Annual Global Investment Conference, being held virtually on September 14-16, 2020.

Click to view original post

Advertise With Us